INVO Bioscience granted 510(k) FDA clearance for expanded use of INVOcell device

INVO Bioscience has received FDA 510(k) clearance to expand the labeling on the INVOcell device and its indication for use to provide for a 5-day incubation period. The data supporting the expanded 5-day incubation clearance demonstrated improved patient outcomes.